Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cost Effectiveness Of Linezolid Vs Vancomycin In The Treatment Of Ventilator Acquired Pneumonia In Central America

NCT01040585 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01040585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01040585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cost Effectiveness Of Linezolid Vs Vancomycin In The Treatment Of Ventilator Acquired Pneumonia In Central America
Lead sponsor
Pfizer
Phase
Observational
Overall status
Withdrawn
Start date
July 31, 2010
Completion date
March 31, 2011
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ventilator acquired pneumonia